Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation.

Boutin L, Arnautou P, Trignol A, Ségot A, Farge T, Desterke C, Soave S, Clay D, Raffoux E, Sarry JE, Malfuson JV, Lataillade JJ, Le Bousse-Kerdilès MC, Anginot A.

Haematologica. 2019 Jul 9. pii: haematol.2018.214379. doi: 10.3324/haematol.2018.214379. [Epub ahead of print]

2.

Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial.

Leleu X, Fouquet G, Richez V, Guidez S, Duhamel A, Machuron F, Karlin L, Kolb B, Tiab M, Araujo C, Meuleman N, Malfuson JV, Bourquard P, Lenain P, Roussel M, Jaccard A, Pétillon MO, Belhadj-Merzoug K, Lepeu G, Chrétien ML, Fontan J, Rodon P, Schmitt A, Offner F, Voillat L, Cereja S, Kuhnowski F, Rigaudeau S, Decaux O, Humbrecht-Kraut C, Frayfer J, Fitoussi O, Roos-Weil D, Eisenmann JC, Dorvaux V, Voog EG, Attal M, Moreau P, Avet-Loiseau H, Hulin C, Facon T.

Clin Cancer Res. 2019 Jul 15;25(14):4224-4230. doi: 10.1158/1078-0432.CCR-18-3642. Epub 2019 May 3.

PMID:
31053600
3.

Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC).

Fayard A, Daguenet E, Blaise D, Chevallier P, Labussière H, Berceanu A, Yakoub-Agha I, Socié G, Charbonnier A, Suarez F, Huynh A, Mercier M, Bulabois CE, Lioure B, Chantepie S, Beguin Y, Bourhis JH, Malfuson JV, Clément L, Peffault de la Tour R, Cornillon J.

Bone Marrow Transplant. 2019 Feb 15. doi: 10.1038/s41409-019-0475-7. [Epub ahead of print]

PMID:
30770870
4.

Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.

Rossi C, Gilhodes J, Maerevoet M, Herbaux C, Morschhauser F, Brice P, Garciaz S, Borel C, Ysebaert L, Obéric L, Lazarovici J, Deau B, Dupuis J, Chauchet A, Abraham J, Bijou F, Stamatoullas-Bastard A, Malfuson JV, Golfier C, Laurent C, Pericart S, Traverse-Glehen A, Kanoun S, Filleron T, Casasnovas RO, Ghesquières H.

Am J Hematol. 2018 Jun 8. doi: 10.1002/ajh.25154. [Epub ahead of print]

5.

[Pyoderma gangrenosum following hematopoietic stem cell transplantation].

Eddou H, Ennouhi A, Sina M, Zinebi A, El Benaye J, Moudden MK, Doghmi K, Malfuson JV, Mikdame M, El Baaj M.

Ann Dermatol Venereol. 2018 Jun - Jul;145(6-7):445-450. doi: 10.1016/j.annder.2018.02.015. Epub 2018 May 7. French.

PMID:
29747867
6.

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation-a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

Gauthier J, Poiré X, Gac AC, Leclerc M, Guillaume T, Chalandon Y, Nguyen S, Forcade E, Régny C, Bay JO, Bazarbachi A, Rohrlich PS, Huynh A, Farhi J, Marchand T, Malfuson JV, Pilorge S, Labussière-Wallet H, Renard C, Fornecker LM, Detrait M, Duléry R, Delage J, Ménard AL, Charbonnier A, Nelken B, Jubert C, Suarez F, de la Tour RP, Beguin Y, Schoemans H, Blaise D, Yakoub-Agha I.

Bone Marrow Transplant. 2018 Apr;53(4):400-409. doi: 10.1038/s41409-017-0018-z. Epub 2018 Jan 12.

7.

Complex upper arm reconstruction using an antero-lateral thigh free flap after an extravasation of Yttrium-90-ibritumomab Tiuxetan: A case report and literature review.

Baus A, Keilani C, Bich CS, Entine F, Brachet M, Duhamel P, Amabile JC, Malfuson JV, Bey E.

Ann Chir Plast Esthet. 2018 Apr;63(2):175-181. doi: 10.1016/j.anplas.2017.11.007. Epub 2017 Dec 28. Review.

PMID:
29290464
8.

[Fracture of unusual cause].

Caré W, Arnautou P, Segot A, de Charry F, Heyraud-Blanchet C, Livartowski J, Konopacki J, Malfuson JV.

Rev Med Interne. 2018 Aug;39(8):665-666. doi: 10.1016/j.revmed.2017.05.001. Epub 2017 Jun 1. French. No abstract available.

PMID:
28579109
9.

Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA.

Wang L, Raffoux E, Thomas X, Yakoub-Agha I, Bouhris JH, de Botton S, Michallet M, Quoc SN, Chantepie S, Deconinck E, Caillot D, Turlure P, Vigouroux S, Pigneux A, Huynh A, Malfuson JV, Loschi M, Socie G, Dombret H, de la Tour RP, Cluzeau T.

Leuk Res. 2017 Mar;54:12-16. doi: 10.1016/j.leukres.2017.01.002. Epub 2017 Jan 5.

PMID:
28088653
10.

Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy.

Gauthier J, Castagna L, Garnier F, Guillaume T, Socié G, Maury S, Maillard N, Tabrizi R, Marchand T, Malfuson J, Gac A, Gyan E, Mercier M, Béguin Y, Delage J, Turlure P, Marçais A, Nguyen S, Dulery R, Bay J, Huynh A, Daguindau E, Cornillon J, Régny C, Michallet M, Peffault de Latour R, Yakoub-Agha I, Blaise D.

Bone Marrow Transplant. 2017 May;52(5):689-696. doi: 10.1038/bmt.2016.349. Epub 2017 Jan 9.

PMID:
28067872
11.

VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial.

Moreau P, Hulin C, Macro M, Caillot D, Chaleteix C, Roussel M, Garderet L, Royer B, Brechignac S, Tiab M, Puyade M, Escoffre M, Stoppa AM, Facon T, Pegourie B, Chaoui D, Jaccard A, Slama B, Marit G, Laribi K, Godmer P, Luycx O, Eisenmann JC, Allangba O, Dib M, Araujo C, Fontan J, Belhadj K, Wetterwald M, Dorvaux V, Fermand JP, Rodon P, Kolb B, Glaisner S, Malfuson JV, Lenain P, Biron L, Planche L, Caillon H, Avet-Loiseau H, Dejoie T, Attal M.

Blood. 2016 May 26;127(21):2569-74. doi: 10.1182/blood-2016-01-693580. Epub 2016 Mar 21.

12.

Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Mamez AC, Lévy V, Chevallier P, Blaise D, Vigouroux S, Xhaard A, Fegueux N, Contentin N, Beguin Y, Ifrah N, Bulabois CE, Suarez F, Yakoub-Agha I, Turlure P, Deconink E, Lamy T, Cahn JY, Huynh A, Maury S, Fornecker LM, Ouzegdouh M, Bay JO, Guillerm G, Maillard N, Michallet M, Malfuson JV, Bourhis JH, Rialland F, Oumedaly R, Jubert C, Leblond V, Boubaya M, Mohty M, Nguyen S.

Bone Marrow Transplant. 2016 Mar;51(3):358-64. doi: 10.1038/bmt.2015.280. Epub 2015 Nov 23.

13.

[Contribution of PET/CT for the management of hepatosplenic candidiasis in hematology].

Jennane S, Eddou H, Mahtat EM, Konopacki J, Souleau B, Malfuson JV, de Revel T.

Med Mal Infect. 2014 Jun;44(6):281-3. doi: 10.1016/j.medmal.2014.03.008. Epub 2014 Apr 29. French. No abstract available.

PMID:
24787634
14.

[Acute myeloid leukemia with t(8;21): unusual cytological presentation and immunophenotype].

Marinier A, Malfuson JV, Konopacki J, Foissaud V, Samson T.

Ann Biol Clin (Paris). 2014 Jan-Feb;72(1):120-3. doi: 10.1684/abc.2013.0922. French.

15.

[Association between multiple myeloma and acute myeloid leukemia secondary to myelodysplastic syndrome].

Jennane S, Eddou H, Mahtat el M, Konopacki J, Souleau B, Malfuson JV, Foissaud V, de Revel T.

Ann Biol Clin (Paris). 2013 Sep-Oct;71(5):581-4. doi: 10.1684/abc.2013.0880. French.

16.

SP/drug efflux functionality of hematopoietic progenitors is controlled by mesenchymal niche through VLA-4/CD44 axis.

Malfuson JV, Boutin L, Clay D, Thépenier C, Desterke C, Torossian F, Guerton B, Anginot A, de Revel T, Lataillade JJ, Le Bousse-Kerdilès MC.

Leukemia. 2014 Apr;28(4):853-64. doi: 10.1038/leu.2013.256. Epub 2013 Sep 3.

PMID:
23999380
17.

[Heterophilic antibodies: be carefull!].

Sanmartin N, Garcia C, Bugier S, Malfuson JV, Chianea D, Renard C, Vest P.

Ann Biol Clin (Paris). 2013 Jul-Aug;71(4):475-80. doi: 10.1684/abc.2013.0858. French.

18.

[Light-chain escape from plateau phase].

Jennane S, Mahtat el M, Konopacki J, Samson T, Foissaud V, Souleau B, Malfuson JV, de Revel T.

Ann Biol Clin (Paris). 2013 Jul-Aug;71(4):469-71. doi: 10.1684/abc.2013.0864. French.

19.

An 8-year survey of strains identified in blood cultures in a clinical haematology unit.

Bousquet A, Malfuson JV, Sanmartin N, Konopacki J, MacNab C, Souleau B, de Revel T, Elouennass M, Samson T, Soler C, Foissaud V, Martinaud C.

Clin Microbiol Infect. 2014 Jan;20(1):O7-12. doi: 10.1111/1469-0691.12294. Epub 2013 Jul 4.

20.

Outcome of older patients with acute myeloid leukemia in first relapse.

Sarkozy C, Gardin C, Gachard N, Merabet F, Turlure P, Malfuson JV, Pautas C, Micol JB, Thomas X, Quesnel B, Celli-Lebras K, Preudhomme C, Terré C, Fenaux P, Chevret S, Castaigne S, Dombret H.

Am J Hematol. 2013 Sep;88(9):758-64. doi: 10.1002/ajh.23498. Epub 2013 Aug 7.

21.

[Signification of Epstein-Barr virus detection in the cerebrospinal fluid of a patient with human immunodeficiency virus related Burkitt lymphoma].

Jennane S, Mahtat el M, Konopacki J, Foissaud V, Souleau B, Malfuson JV, De Revel T.

Ann Biol Clin (Paris). 2013 May-Jun;71(3):341-4. doi: 10.1684/abc.2013.0814. French.

22.

[Cutaneous pseudolymphoma as an alternative presentation of IgG4 related disease].

Eddou H, Le Guyadec T, Cremades A, Saint Blancard P, Malfuson JV, Konopacki J, de Revel T.

Ann Biol Clin (Paris). 2013 May-Jun;71(3):333-7. doi: 10.1684/abc.2013.0817. French.

23.

Cyclosporine-related posterior reversible encephalopathy syndrome after cord blood stem cell transplantation.

Jennane S, Mahtat el M, Konopacki J, Malfuson JV, Doghmi K, Mikdame M, De Revel T.

Hematol Oncol Stem Cell Ther. 2013 Jun;6(2):71. doi: 10.1016/j.hemonc.2013.05.002. Epub 2013 May 23. No abstract available.

24.

Peripherally inserted central catheter placement in cancer patients with profound thrombocytopaenia: a prospective analysis.

Potet J, Thome A, Curis E, Arnaud FX, Weber-Donat G, Valbousquet L, Peroux E, Flor E, Dody C, Konopacki J, Malfuson JV, Cartry C, Lahutte M, de Revel T, Baccialone J, Teriitehau CA.

Eur Radiol. 2013 Jul;23(7):2042-8. doi: 10.1007/s00330-013-2778-1. Epub 2013 Feb 26.

PMID:
23440314
25.

[Plasmacytoïd dendritic cells acute leukemia: a case report].

Bousquet A, Doutrelon C, Konopacki J, Marfaing-Koka A, Segot A, Martinaud C, Samson T, Souleau B, Malfuson JV, De Revel T, Foissaud V.

Ann Biol Clin (Paris). 2012 Oct 1;70(5):617-21. doi: 10.1684/abc.2012.0752. French.

26.

Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapse.

Malfuson JV, Konopacki J, Thepenier C, Eddou H, Foissaud V, de Revel T.

Ann Hematol. 2012 Dec;91(12):1871-7. doi: 10.1007/s00277-012-1528-9. Epub 2012 Jul 21.

PMID:
22820971
27.

Campylobacter jejuni cutaneous infection in a patient with graft versus host disease.

Bousquet A, Demoures T, Malfuson JV, Martinaud C, Soler C.

Med Mal Infect. 2012 May;42(5):235-6. doi: 10.1016/j.medmal.2012.04.005. Epub 2012 May 15. No abstract available.

PMID:
22595471
28.

Effectiveness and safe use of modified FOLFOX-6 for metastatic gastric cancer with signet ring cell components complicated by disseminated intravascular coagulation and diffuse bone marrow carcinomatosis.

Ferrand FR, Gontier E, Guymar S, Fagot T, Ceccaldi B, Malfuson JV, de Revel T.

Onkologie. 2012;35(3):118-20. doi: 10.1159/000336971. Epub 2012 Feb 20.

PMID:
22414976
29.

[Primary granulocytic sarcoma of the peritoneum: a case report and literature review].

Eddou H, El Bouzidi A, Valero E, Helissey C, Malfuson JV, De Revel T, Doghmi K, Mikdame M.

Ann Biol Clin (Paris). 2012 Jan-Feb;70(1):93-7. doi: 10.1684/abc.2011.0656. Review. French.

30.

[Evans syndrome: be careful of over-diagnosis].

Eddou H, Helissey C, Konopacki J, Souleau B, de Revel T, Malfuson JV.

Rev Med Interne. 2012 Mar;33(3):155-8. doi: 10.1016/j.revmed.2011.12.006. Epub 2012 Jan 26. French.

PMID:
22280850
31.

Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?

Itzykson R, Thépot S, Beyne-Rauzy O, Ame S, Isnard F, Dreyfus F, Salanoubat C, Taksin AL, Chelgoum Y, Berthon C, Malfuson JV, Legros L, Vey N, Turlure P, Gardin C, Boehrer S, Ades L, Fenaux P; Groupe Francophone des Myelodysplasies (GFM).

Leuk Res. 2012 Apr;36(4):397-400. doi: 10.1016/j.leukres.2011.11.019. Epub 2011 Dec 15.

PMID:
22177456
32.

Infectious mononucleosis and monoclonal B lymphocytosis in an elderly man.

Malfuson JV, Dutasta F, Konopacki J, de Revel T, Soler C, Samson T.

J Am Geriatr Soc. 2011 Nov;59(11):2156-7. doi: 10.1111/j.1532-5415.2011.03771.x. No abstract available.

PMID:
22098030
33.

[Pneumonia and Rothia dentocariosa].

Bousquet A, Soler C, Martinaud C, Join-Lambert O, Malfuson JV.

Med Mal Infect. 2011 Nov;41(11):621-2. doi: 10.1016/j.medmal.2011.07.011. Epub 2011 Sep 9. French. No abstract available.

PMID:
21908119
34.

Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia.

Malfuson JV, Konopacki J, Fagot T, Desangles F, Bories D, Souleau B, de Revel T.

Ann Hematol. 2011 Dec;90(12):1477-9. doi: 10.1007/s00277-011-1188-1. Epub 2011 Feb 25. No abstract available.

PMID:
21350831
35.

Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome.

Raffoux E, Cras A, Recher C, Boëlle PY, de Labarthe A, Turlure P, Marolleau JP, Reman O, Gardin C, Victor M, Maury S, Rousselot P, Malfuson JV, Maarek O, Daniel MT, Fenaux P, Degos L, Chomienne C, Chevret S, Dombret H.

Oncotarget. 2010 May;1(1):34-42.

36.

[Acute respiratory distress revealing acute myeloblastic leukaemia: case report].

Malfuson JV, Margery J, Bonnichon A, Fagot T, Souleau B, Samson T, de Revel T.

Rev Pneumol Clin. 2010 Sep;66(4):276-80. doi: 10.1016/j.pneumo.2010.07.004. French.

PMID:
20933171
37.

Which role for rituximab in hairy cell leukemia? Reflections on six cases.

Malfuson JV, Fagot T, Konopacki J, Souleau B, Cremades S, de Revel T.

Acta Haematol. 2010;123(2):110-6. doi: 10.1159/000270903. Epub 2009 Dec 24. Review.

PMID:
20051682
38.

JAK1 mutations are not frequent events in adult T-ALL: a GRAALL study.

Asnafi V, Le Noir S, Lhermitte L, Gardin C, Legrand F, Vallantin X, Malfuson JV, Ifrah N, Dombret H, Macintyre E.

Br J Haematol. 2010 Jan;148(1):178-9. doi: 10.1111/j.1365-2141.2009.07912.x. Epub 2009 Sep 18. No abstract available.

PMID:
19764985
39.

Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.

Pierre-Louis O, Clay D, Brunet de la Grange P, Blazsek I, Desterke C, Guerton B, Blondeau C, Malfuson JV, Prat M, Bennaceur-Griscelli A, Lataillade JJ, Le Bousse-Kerdilès MC.

Stem Cells. 2009 Oct;27(10):2552-62. doi: 10.1002/stem.186.

40.

[Hematological disorders and hypereosinophilias].

Malfuson JV, Fagot T, Konopacki J, Mangouka L, Souleau B, de Revel T.

Rev Med Interne. 2009 Apr;30(4):322-30. doi: 10.1016/j.revmed.2008.10.019. Epub 2009 Feb 7. French.

PMID:
19201511
41.

Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia.

Malfuson JV, Etienne A, Turlure P, de Revel T, Thomas X, Contentin N, Terré C, Rigaudeau S, Bordessoule D, Vey N, Gardin C, Dombret H; Acute Leukemia French Association (ALFA).

Haematologica. 2008 Dec;93(12):1806-13. doi: 10.3324/haematol.13309. Epub 2008 Oct 6.

42.

[ABO incompatibility and non myeloablative allogeneic stem cell transplantation].

Malfuson JV, Hicheri Y, Bonin P, Rodet M, Boccaccio C, Pautas C, Kuentz M, Cordonnier C, Noizat-Pirenne F, Maury S.

Transfus Clin Biol. 2007 Aug;14(3):327-33. Epub 2007 Apr 25. Review. French.

PMID:
17462938
43.

Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantation.

Malfuson JV, Amor RB, Bonin P, Rodet M, Boccaccio C, Pautas C, Kuentz M, Cordonnier C, Noizat-Pirenne F, Maury S.

Vox Sang. 2007 Jan;92(1):85-9.

PMID:
17181595
44.

[Efficacy of rituximab in hairy cell leukemia].

Malfuson JV, Doghmi K, Fagot T, Souleau B, De Revel T, Nedellec G.

Presse Med. 2006 May;35(5 Pt 1):801-2. French.

PMID:
16710151
45.

[Hodgkin's disease with bone marrow involvement. The role of positron tomography].

Doghmi K, Malfuson JV, El Ouennass M, Fagot T, Forel A, Branquet D, Foissaud V, Samson T, de Revel T, Nedellec G.

Presse Med. 2005 Feb 12;34(3):227-9. French.

PMID:
15798535
46.

[A 7-year survey of strains identified in blood cultures in a clinical hematology unit].

Elouennass M, Foissaud V, Trueba F, Doghmi K, Malfuson JV, Fagot T, Mac Nab C, Samson T, Souleau B, de Revel T, Nedellec G, Hervé V.

Med Mal Infect. 2004 Feb;34(2):62-9. French.

PMID:
15620016
47.

[Hairy-cell leukemia: 30 cases and a review of the literature].

Malfuson JV, Gisserot O, Cremades S, Doghmi K, Fagot T, Souleau B, de Revel T, de Jaureguiberry JP, Nedellec G.

Ann Med Interne (Paris). 2003 Nov;154(7):435-40. Review. French.

PMID:
14732834

Supplemental Content

Loading ...
Support Center